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Summary
Background: Maternal caffeine intake during pregnancy is associated with an
increased risk of childhood obesity. Studies in adults suggest that caffeine intake
might also directly affect visceral and liver fat deposition, which are strong risk fac-
tors for cardio-metabolic disease.
Objective: To assess the associations of maternal caffeine intake during pregnancy
with childhood general, abdominal, and liver fat mass at 10 years of age.
Methods: In a population-based cohort from early pregnancy onwards among 4770
mothers and children, we assessed maternal caffeine intake during pregnancy and
childhood fat mass at age 10 years.
Results: Compared with children whose mothers consumed <2 units of caffeine per
day during pregnancy, those whose mothers consumed 4-5.9 and ≥6 units of caffeine
per day had a higher body mass index, total body fat mass index, android/gynoid fat
mass ratio, and abdominal subcutaneous and visceral fat mass indices. Children
whose mothers consumed 4-5.9 units of caffeine per day had a higher liver fat frac-
tion. The associations with abdominal visceral fat and liver fat persisted after taking
childhood total body fat mass into account.
Conclusions: High maternal caffeine intake during pregnancy was associated with
higher childhood body mass index, total body fat, abdominal visceral fat, and liver fat.
The associations with childhood abdominal visceral fat and liver fat fraction were
independent of childhood total body fat. This suggests differential fat accumulation
in these depots, which may increase susceptibility to cardio-metabolic disease in
later life.
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1 | INTRODUCTION
Caffeine is a methylxantine that occurs naturally in several food prod-
ucts. Caffeine-containing beverages, including coffee and tea, are
widely consumed by pregnant women. Caffeine crosses the placenta
and enters the fetal circulation freely.1 The activity of the principal
enzyme in caffeine metabolism, cytochrome CYP1A2, decreases pro-
gressively during pregnancy and is absent in placenta and fetus.2-4 As
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a consequence, fetal exposure to caffeine is prolonged and might
adversely influence the development of organ systems. Consumption
of caffeine-containing beverages during pregnancy has been related
to an increased risk of fetal death, impaired fetal growth, and low birth
weight.5-9 In addition to these short-term outcomes, maternal caffeine
intake during pregnancy may also influence long-term offspring body
fat development. We previously observed among 7857 mothers and
their children from the Netherlands that high maternal caffeine intake
during pregnancy was associated with a higher childhood body mass
index and total body fat mass at the age of 6 years.10 Similarly, studies
among 615, 50 943, and 558 mothers and children from the United
States, Norway, and Ireland, respectively, observed that any maternal
caffeine intake during pregnancy was associated with an increased
risk of obesity in childhood.11-13
In contrast, consumption of caffeine-containing beverages by
non-pregnant adults seems to have beneficial effects on body fat
accumulation and the risks of several diseases.14-19 Previous studies
suggest that consumption of caffeine-containing beverages is associ-
ated with lower visceral fat accumulation and lower risks of non-
alcoholic fatty liver disease (NAFLD), possibly by influencing blood
concentrations of adiponectin and pro-inflammatory cytokines.15-19
Previous research suggests that blood concentrations of adipokines
and cytokines in pregnant women are related to childhood body fat
development.20-22 However, it is not known whether maternal caf-
feine intake during pregnancy is also related to offspring abdominal
and liver fat accumulation. Thus far, only animal studies have shown
that in utero exposure to caffeine increases intra-hepatic fat content
and the susceptibility to NAFLD.23,24 As visceral and liver fat accumu-
lation are related to the development of hypertension, type 2 diabetes,
NAFLD, and the metabolic syndrome independent of excess body fat
per se,25,26 it is important to obtain further insight into whether
maternal caffeine intake during pregnancy differentially affects off-
spring visceral and liver fat deposition.
Therefore, in a population-based cohort among 4770 mothers
and children from early pregnancy onwards, we assessed the associa-
tions of maternal caffeine intake during pregnancy with childhood
general, abdominal, and liver fat at the age of 10 years, with the main
focus on abdominal and liver fat.
2 | METHODS
2.1 | Study design
This study was embedded in the Generation R Study, a prospective
population-based cohort study from early pregnancy onwards per-
formed in Rotterdam, the Netherlands.27 The study was approved by
the Medical Ethical Committee of the Erasmus Medical Center, Uni-
versity Medical Center, Rotterdam (MEC 198.782/2001/31). Written
informed consent was obtained from all mothers at enrolment in the
study. The response rate at birth was 61%. Of the 8879 mothers that
were prenatally included in the study, 8097 had information available
on caffeine intake during pregnancy. Of their children, 7900 were
singleton and live born. Of these children, 4770 participated in body
composition follow-up measurements at 10 years of age and were
included in the analyses (Figure S1).
2.2 | Maternal caffeine intake during pregnancy
As described previously, information on maternal caffeine intake from
coffee and tea during pregnancy was obtained by postal question-
naires in the first, second, and third trimesters of pregnancy.7,10
Response rates for these questionnaires were 91%, 80%, and 77%,
respectively.7,10 Mothers who reported to drink any coffee or tea
were asked how many cups of coffee or tea they consumed on aver-
age per day and what type of coffee or tea they consumed (caffein-
ated, decaffeinated, or a combination of both). According to standard
values for caffeine content, a regular coffee serving (125 mL) in the
Netherlands contains ~90 mg caffeine, decaffeinated coffee contains
~3 mg, and black tea contains ~45 mg.28 To calculate the total caf-
feine intake in each trimester, the type of coffee or tea was weighted
according to its caffeine content (caffeinated coffee = 1, caffeinated
and decaffeinated coffee = 0.5, decaffeinated coffee = 0,
caffeinated tea = 0.5, caffeinated and decaffeinated tea = 0.25, decaf-
feinated tea = 0, herbal tea = 0, and green tea = 0.5).7 Thus, in our
analyses, each unit of caffeine intake reflects caffeine exposure based
on one cup of caffeinated coffee (90 mg caffeine).10 Based on data
availability, total caffeine intake was categorized into categories of <2,
2-3.9, 4-5.9, and ≥6 units per day (equivalent to <180, 180-359,
360-539, and ≥540 mg per day, respectively). For the main analyses
using caffeine intake during the full pregnancy, caffeine intake of the
trimesters was averaged.
2.3 | Childhood body fat mass
At the age of 10 years, we measured height and weight without
shoes and heavy clothing and calculated body mass index (kg/m2).
We created age- and sex-adjusted standard deviation scores (SDS)
of body mass index using a Dutch reference chart.29 In addition, we
defined childhood overweight/obesity according to the International
Obesity Task Force cut-offs.30 We measured total and regional body
fat mass using dual-energy X-ray absorptiometry (DXA) (iDXA, Gen-
eral Electrics–Lunar, 2008, Madison, Wisconsin).31 Android/gynoid
fat mass ratio was calculated and used as a measure of body fat dis-
tribution comparable with waist/hip ratio.31 Abdominal and organ
fat were measured in a subgroup by magnetic resonance imaging
(MRI), as described previously.27 Briefly, all children were scanned
using a 3.0 Tesla MRI (Discovery MR750w, General Electric
Healthcare, Milwaukee, Wisconsin). The MRI protocol included an
axial 3-point Dixon sequence for fat and water separation (IDEAL
IQ) for liver fat measurements. This technique also enables the gen-
eration of liver fat fraction images.32 An axial abdominal scan from
lower liver to pelvis and a coronal scan centred at the head of the
femurs were also performed with a 2-point Dixon acquisition
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(LavaFlex). The obtained fat scans were analysed by the Precision
Image Analysis company (PIA, Kirkland, Washington), using the sli-
ceOmatic (TomoVision, Magog, Canada) software package. All extra-
neous structures and any image artefacts were removed manually.33
Total subcutaneous and visceral fat volumes ranged from the dome
of the liver to the superior part of the femoral head. Fat masses
were obtained by multiplying the total volumes by the specific grav-
ity of adipose tissue, 0.9 g/mL. Liver fat fraction was determined by
defining four regions of interest of at least 4 cm2 in the central por-
tion of the hepatic volume. Subsequently, the mean signal intensi-
ties were averaged to generate an overall mean liver fat fraction
estimation. To create fat measures independent of child's height, we
estimated the optimal adjustment by log-log regression analyses and
subsequently divided total and subcutaneous fat mass by height3
(total body fat mass index and subcutaneous fat mass index) and
visceral fat mass by height4 (visceral fat mass index, Methods
S1).34,35
2.4 | Covariates
Information on maternal age, pre-pregnancy body mass index, parity,
ethnicity, educational level, and folic acid supplementation use was
obtained by questionnaire at enrolment in the study. Smoking and
alcohol intake during pregnancy were repeatedly assessed by ques-
tionnaire. Information on gestational diabetes, gestational hyperten-
sive disorders (gestational hypertension and pre-eclampsia), date of
birth, child's sex, and birth weight was obtained from midwife and
hospital registries. Average television watching time was assessed by
questionnaire at the age of 10 years.
2.5 | Statistical analysis
First, we performed a non-response analysis comparing participants
included the analysis with those lost to follow up at the age of
10 years. Second, we assessed the associations of maternal caffeine
intake during pregnancy with childhood general fat measures and
the risk of overweight/obesity at age 10, using linear and logistic
regression models. Third, we assessed the associations of maternal
caffeine intake during pregnancy with childhood abdominal subcuta-
neous and visceral fat mass indices and liver fat fraction, using linear
regression models. Non-normally distributed outcome variables were
log-transformed. To enable comparison of effect estimates across
the different outcomes, we calculated SDS for each of the out-
comes. The models were first adjusted for child's age and sex only
(basic models). Next, we additionally adjusted the models for mater-
nal ethnicity, education, smoking during pregnancy, alcohol con-
sumption during pregnancy, folic acid supplementation use, and
childhood television watching time (confounder models). These con-
founders were selected based on existing literature, associations
with the exposure and outcome in the study sample, and a change
in effect estimates of >10%. Maternal age, pre-pregnancy body
mass index, parity, and gestational hypertensive disorders were also
considered, but were not associated with either the exposure or the
outcome or did not change the effect estimates with >10% and
were therefore not included in the models. To explore whether any
observed associations of caffeine intake during pregnancy with the
outcomes were mediated by gestational age at birth and birth
weight, we added these variables to the confounder models (media-
tor models). We performed tests for trend by adding the catego-
rized caffeine intake variable to the models as continuous variable.
Fourth, to further explore whether maternal caffeine intake during
pregnancy was specifically associated with childhood abdominal fat
mass and liver fat fraction, independent from total body fat mass,
we used conditional regression analyses. We created measures of
childhood abdominal subcutaneous fat mass, abdominal visceral fat
mass, and liver fat fraction that are independent of total body fat
mass by regressing these detailed childhood fat measures on child-
hood total body fat mass index. The standardized residuals from
these models were used as an outcome for the regression models
focused on the associations of maternal caffeine intake during preg-
nancy with conditional childhood abdominal and liver fat mea-
sures.36 Fifth, to identify potential critical periods, we assessed the
associations of trimester-specific maternal caffeine intake with child-
hood general, abdominal, and liver fat using linear regression
models. As sex differences in childhood body fat development have
been reported,37,38 we tested for interactions between maternal caf-
feine intake during pregnancy and child's sex, but these interaction
terms were not statistically significant (P values > .05). Missing
values of covariates (maximum percentage of missing values: 20.8%)
were imputed using Multiple Imputation, and pooled results from
five imputed datasets were reported. All statistical tests were two-
sided, with a significance threshold of 0.05. The analyses were per-
formed using the Statistical Package for the Social Sciences version
24.0 (IBM Corp, Armonk, New York, USA) and R version 3.3.4
(R Foundation for Statistical Computing).
3 | RESULTS
3.1 | Participants' characteristics
Table 1 shows that, of the 4770 women included, 2780 (58.3%), 1583
(33.2%), 329 (6.9%), and 78 (1.6%) consumed <2 units, 2-3.9 units,
4-5.9 units, and ≥6 units of caffeine per day, respectively, during preg-
nancy. Women who had higher caffeine intakes were older and were
more likely to be higher educated, multiparous, and from European
descent. They used less often folic acid supplementation and smoked
and consumed alcohol more often during pregnancy. Table S1 shows
that, as compared with women included in the analyses, those lost to
follow up had slightly lower caffeine intakes and a lower pre-
pregnancy BMI, were younger, were more often multiparous, and
were less often from European descent. These women used folic sup-
plementation less often, smoked more often, and consumed alcohol
less often during pregnancy.
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TABLE 1 Characteristics of the mothers and their children
Total Group <2 Units 2-3.9 Units 4-5.9 Units ≥6 Units
P Value
N = 4770 N = 2780 (58.3%) N = 1583 (33.2%) N = 329 (6.9%) N = 78 (1.6%)
Maternal characteristics
Caffeine intake during
pregnancy, median (95%
range), units
1.6 (0.0-5.2) 1.0 (0.0-1.8) 2.6 (2.0-3.8) 4.5 (4.0-5.7) 6.7 (6.0-10.3) <.001
Age, median (95% range), y 31.2 (20.4-39.6) 30.4 (19.6-39.1) 32.0 (21.9-40.1) 32.9 (23.5-39.8) 33.7 (23.2-40.8) <.001
Pre-pregnancy BMI, median
(95% range), kg/m2
22.6 (18.1-34.5) 22.6 (18-34.6) 22.4 (18.3-34.1) 22.8 (18.5-34.5) 22.7 (18.4-31.5) .242
Education, N (%)
Primary 340 (7.4) 233 (8.7) 87 (5.6) 13 (4.0) 7 (9.2) <.001
Secondary 1944 (42.2) 1247 (46.7) 543 (35.3) 116 (36.1) 38 (50.0)
Higher 2324 (50.4) 1191 (44.6) 910 (59.1) 192 (59.8) 31 (40.8)
Parity, nulliparous (%) 2793 (58.8) 1715 (62.0) 873 (55.4) 168 (51.1) 37 (47.4) <.001
Ethnicity, European (%) 3113 (65.8) 1624 (59.1) 1163 (73.8) 264 (80.7) 62 (80.5) <.001
Folic acid supplementation
use, Yes (%)
2955 (78.2) 1663 (75.9) 1039 (81.7) 216 (82.4) 37 (67.3) <.001
Smoking during pregnancy,
Yes (%)
1065 (24.3) 493 (19.3) 412 (28.3) 116 (38.3) 44 (58.7) <.001
Alcohol consumption during
pregnancy, Yes (%)
2495 (57.5) 1271 (50.2) 969 (67.3) 203 (69.0) 52 (70.3) <.001
Gestational hypertensive
disorders, Yes (%)
272 (5.9) 166 (6.2) 80 (5.2) 22 (6.8) 4 (5.3) NA
Gestational diabetes, Yes (%) 46 (1.0) 26 (1.0) 15 (1.0) 5 (1.6) 0 (0.0) NA
Child characteristics
Males, No. (%) 2361 (49.5) 1410 (50.7) 732 (46.2) 176 (53.5) 43 (55.1) .009
Gestational age at birth,
median (95% range), wk
40.1 (35.9-42.3) 40.1 (35.5-42.3) 40.3 (36.4-42.3) 40.3 (36.0-42.4) 40.3 (34.5-42.4) .023
Birth weight, median (95%
range), g
3460 (2262-4480) 3450 (2250-4430) 3490 (2368-4520) 3530 (2392-4534) 3390 (1999-4263) .007
Gestational age adjusted birth
weight, mean (SD)
−0.1 (1.0) −0.1 (1.0) 0.0 (1.0) 0.0 (1.1) −0.3 (1.1) .027
Ever breastfeeding, Yes (%) 3627 (92.6) 2063 (92.3) 1244 (93.3) 266 (92.7) 54 (91.5) NA
Introduction of solid foods,
before 6 mo (%)
2800 (89.1) 1569 (88.7) 979 (89.4) 214 (90.7) 38 (90.5) NA
Age at 10-y follow-up
measurement, median
(95% range), y
9.7 (9.4-10.7) 9.7 (9.3-10.8) 9.7 (9.4-10.7) 9.7 (9.4-10.4) 9.7 (9.3-10.3) .650
Television watching, More
than 2 h/d (%)
1168 (30.9) 717 (33.3) 346 (26.8) 80 (28.7) 25 (40.3) <.001
Body mass index at 10 y,
median (95% range), kg/m2
17.0 (14.0-24.8) 17.0 (14.0-25.1) 16.8 (14.1-24.2) 17.2 (14-24.1) 17.8 (14.3-24.0) <.001
Overweight, N (%) 862 (3.7) 556 (16.2) 231 (11.8) 54 (13.8) 21 (22.0) NA
Total body fat mass, median
(95% range), kg
8.5 (4.5-22.0) 8.6 (4.5-22.2) 8.4 (4.5-21.7) 8.5 (4.8-21.9) 9.7 (4.6-20.9) .044
Android/gynoid fat mass
ratio, median (95% range)
0.2 (0.2, 0.5) 0.2 (0.2, 0.5) 0.2 (0.2, 0.5) 0.2 (0.2, 0.5) 0.3 (0.2, 0.5) .023
Abdominal subcutaneous fat,
median (95% range), kg
1.3 (0.6, 5.4) 1.3 (0.6, 5.4) 1.3 (0.6, 4.9) 1.4 (0.7, 4.7) 1.5 (0.8, 6.2) .017
Abdominal visceral fat,
median (95% range), kg
0.4 (0.2, 1.0) 0.4 (0.2, 1.0) 0.4 (0.2, 0.9) 0.4 (0.2, 0.9) 0.5 (0.2, 1.2) .002
Liver fat fraction, median
(95% range), %
2.0 (1.2, 5.2) 2.0 (1.2, 5.3) 2.0 (1.3, 4.6) 2.1 (1.4, 5.4) 2.1 (1.3, 8.4) .444
Note: Values represent mean (SD), median (95% range) or number of participants (valid %). One unit of caffeine represents the equivalent of one cup of
coffee (90 mg of caffeine). NA: Chi-square test not available as a result of low expected cell counts.
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3.2 | Maternal caffeine intake during pregnancy
and childhood general body fat mass
Figure 1 shows that in the confounder model, as compared with children
whose mothers consumed <2 units of caffeine per day during pregnancy,
those whose mothers consumed 4-5.9 and ≥6 units of caffeine per day
during pregnancy had a higher body mass index (differences: 0.12 stan-
dard deviation [SD] [95% confidence interval (CI), 0.01-0.24] and 0.24
[95% CI, 0.01-0.47], respectively), total body fat mass index (differences:
0.14 SD [95% CI, 0.04-0.25] and 0.22 [95% CI, 0.02-0.43], respectively),
and android/gynoid fat mass ratio (differences: 0.16 SD [95% CI,
0.05-0.27] and 0.22 [95% CI, 0.01-0.44], respectively) at the age of
10 years (exact differences are given in Table S2). A dose-response rela-
tionship was present for each of these outcomes (P-values for
trend < .05). Children whose mothers consumed ≥6 units of caffeine per
day also tended to have a higher risk of overweight/obesity (odds ratio:
1.59 [95% CI, 0.92-2.75], Figure 2). Results from the basic model were
similar (Table S3). Additional adjustment for gestational age at birth and
birth weight did not change the results (Table S4). Table S5 shows that
no trimester-specific associations were present, but rather that associa-
tions were similar across pregnancy.
3.3 | Maternal caffeine intake during pregnancy
and childhood abdominal fat mass and liver fat
fraction
Figure 3A shows that in the confounder model, as compared with
children whose mothers consumed <2 units of caffeine per day
during pregnancy, those whose mothers consumed 4-5.9 and
≥6 units of caffeine per day during pregnancy had a higher abdom-
inal subcutaneous fat mass index (differences: 0.15 SD [95% CI,
−0.01 to 0.30] and 0.35 SD [95% CI, 0.04-0.65], respectively) and
a higher abdominal visceral fat mass index (differences: 0.14 SD
[95% CI, −0.03 to 0.30] and 0.43 SD [95% CI, 0.11-0.76], respec-
tively). Children whose mothers consumed 4-5.9 units of caffeine
per day also had a higher liver fat fraction, as compared with those
whose mothers consumed <2 units per day during pregnancy (dif-
ference: 0.20 SD [95% CI, 0.04-0.36]); exact differences are given
in Table S6). A dose-response relationship was present for each of
the outcomes (P values for trend < .05). Results from the basic
model were similar (Table S7). Additional adjustment for gestational
age at birth and birth weight did not influence the observed esti-
mates (Table S8). Table S9 shows that the associations for each tri-
mester separately were comparable with those for the full
pregnancy.
Figure 3B shows that after conditioning on total body fat mass
index to assess the effects of maternal caffeine intake during preg-
nancy on childhood abdominal fat and liver fat fraction indepen-
dent of childhood total body fat, maternal caffeine intake during
pregnancy of ≥6 units and 4-5.9 units per day remained associated
with abdominal visceral fat mass index and liver fat fraction,
respectively (differences: 0.32 SD [95% CI, 0.00-0.64] and 0.20 SD
[95% CI, 0.04-0.36]). A significant dose-response relationship
remained also present for these outcomes (P values for
trend < .05). No associations were present with childhood abdomi-
nal subcutaneous fat mass index conditioned on childhood total
body fat mass index.
P for trend: 0.048
N=2,768 N=1,579 N=329 N=78
P for trend: 0.008
N=2,732 N=1,559 N=327 N=78
P for trend: 0.003
N=2,741 N=1,562 N=327 N=78
Body mass index (N=4,754) Total fat mass index (N=4,696) Android/gynoid fat mass ratio (N=4,708)
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F IGURE 1 Associations of maternal caffeine intake during pregnancy with childhood general body fat mass. Values are regression
coefficients (95% confidence intervals) from the confounder models that reflect the difference in childhood body mass index, total body fat mass
index, android/gynoid fat mass ratio in children of mothers who consumed 2-3.9, 4-5.9, and ≥6 units of caffeine per day, as compared with those
whose mothers consumed <2 units of caffeine per day. One unit of caffeine represents the equivalent of one cup of coffee (90 mg). The models
are adjusted for child's sex, child's age at follow-up measurement, maternal ethnicity, maternal education, maternal smoking, maternal alcohol use,
folic acid supplementation, and television watching time. P values for trend were obtained from models in which the categorized caffeine intake
variable (<2, 2-3.9, 4-5.9, and ≥6 units) was entered as continuous variable
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4 | DISCUSSION
In this population-based prospective cohort study, high maternal caf-
feine intake during pregnancy was associated with higher childhood
general body fat mass, abdominal fat mass, and liver fat fraction at the
age of 10 years. The associations of high maternal caffeine intake with
childhood abdominal visceral fat mass and liver fat fraction seemed to
be independent from childhood total body fat mass.
4.1 | Interpretation of main findings
Caffeine-containing beverages are frequently consumed during preg-
nancy. Increasing evidence suggests that maternal caffeine intake dur-
ing pregnancy might be related to long-term offspring body fat
development.10-12,39 We previously showed among 7857 6-year-old
children from the same cohort as the current study that maternal caf-
feine intake during pregnancy of ≥4 units per day was associated with
a higher body mass index and total body fat mass. Maternal caffeine
intake during pregnancy of ≥6 units per day was also associated with
a higher android/gynoid fat mass ratio, reflecting a central body fat
accumulation.10 A study among 272 mother-child pairs from Brazil
observed that any caffeine intake by women with an uncomplicated
pregnancy was associated with a higher offspring sum of skinfold
thicknesses at age 3 months.39 A study among 50 943 participants
from Norway showed that any caffeine intake during pregnancy was
associated with an increased risk of childhood overweight at ages
3 and 5, whereas at 8 years, this association was only present for high
caffeine intakes.12 In an Irish study among 558 mother-child pairs,
higher maternal caffeine intake during pregnancy was associated with
higher risks of overall and central obesity at the ages of 5 and
9 years.13 In line with these previous studies, we observed in the cur-
rent study that higher maternal caffeine intake during pregnancy was
associated with higher body mass index, total body fat mass, and
android/gynoid fat mass ratio at the age of 10 years, as indicated by
significant tests for trend. The strongest effects were present for
maternal caffeine intake during pregnancy 4 or more units per day.
For instance, as compared with children whose mothers consumed
<2 units of caffeine per day, children whose mothers consumed
≥6 units of caffeine per day during their pregnancy had a 0.24 SD
higher body mass index, corresponding to a difference of approxi-
mately 0.7 kg/m2. These effect sizes are comparable with those
observed for well-known determinants of childhood body mass index,
such as maternal pre-pregnancy overweight and smoking during preg-
nancy.40-42 These associations were similar across the trimesters of
pregnancy. Mothers with high caffeine intakes during pregnancy also
had higher alcohol intakes and smoked more often during their preg-
nancies. However, associations were present across the full range of
maternal caffeine intake, and adjusting the models for these lifestyle-
related factors did not influence the results. We therefore do not con-
sider it likely that the observed associations can be fully explained by
differences in these factors. Thus, these findings suggest that mater-
nal caffeine intake throughout pregnancy has long-term consequences
for offspring body fat development, as reflected by higher total body
fat mass and a central body fat distribution.
Studies in adults suggest that consumption of caffeine-
containing beverages might also be associated with abdominal and
ectopic fat deposition, although the direction of these associations
might be different from the direction of the associations of maternal
caffeine intake during pregnancy with offspring body fat develop-
ment.15-19 A study among 364 Japanese men showed inverse asso-
ciations of coffee consumption with visceral fat mass and visceral to
P for trend: 0.996
N=2,565 N=1,476 N=306 N=74
Overweight/obesity (N=4,421)
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F IGURE 2 Associations of maternal caffeine intake during pregnancy with the risk of childhood overweight/obesity. Values are odds ratios
(95% confidence intervals) from the confounder models that reflect the risk of overweight/obesity in children of mothers who consumed 2-3.9,
4-5.9, and ≥6 units of caffeine per day, as compared with those whose mothers consumed <2 units of caffeine per day. One unit of caffeine
represents the equivalent of one cup of coffee (90 mg). The models are adjusted for child's sex, child's age at follow-up measurement, maternal
ethnicity, maternal education, maternal smoking, maternal alcohol use, folic acid supplementation, and television watching time. P values for trend
were obtained from models in which the categorized caffeine intake variable (<2, 2-3.9, 4-5.9, and ≥ 6 units) was entered as continuous variable
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subcutaneous fat mass ratio.15 A meta-analysis of five studies
showed that the risk of NAFLD was 30% lower in participants who
consumed coffee as compared with those who did not.18 It is not
known whether caffeine intake by pregnant women is also related
to offspring fat deposition in these specific fat depots. Only one
study, among 7857 participants from our cohort from the Nether-
lands, showed that maternal caffeine intake during pregnancy was
not associated with pre-peritoneal fat mass measured by abdominal
ultrasound at age 6, which was used as proxy of visceral fat.10 In
the current study, we observed that higher maternal caffeine intake
during pregnancy was associated with higher childhood abdominal
subcutaneous fat mass, abdominal visceral fat mass, and liver fat
fraction measured by MRI at age 10. This inconsistency might be
explained by differences in measures of abdominal visceral fat mass.
Pre-peritoneal fat mass provides an estimation of abdominal visceral
fat mass, while MRI provides more precise measures and is the gold
standard for the measurement of intra-abdominal and organ fat
deposition.33 Also, the associations of maternal caffeine intake dur-
ing pregnancy might only become apparent at older childhood ages.
The results for each of the trimesters separately were comparable
with those for the full pregnancy. The associations with abdominal
visceral fat mass and liver fat fraction persisted after taking total
body fat mass into account. This suggests that maternal caffeine
intake throughout pregnancy might differentially affect fat deposi-
tion in these depots in the offspring, independent of their total
body fat development. As visceral and liver fat accumulation are
related to the development of cardio-metabolic disease indepen-
dently of total body fat, these children might be at risk of later
cardio-metabolic disease.25,26 The associations with abdominal sub-
cutaneous fat mass were not independent from total body fat mass.
P for trend: 0.023
N=1,405 N=797 N=153 N=36
P for trend: 0.003
N=1,406 N=797 N=153 N=36
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P for trend: 0.774
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P for trend: 0.044
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P for trend: 0.023
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Abdominal or liver fat measure conditional on total fat mass index
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B
F IGURE 3 Associations of maternal caffeine intake during pregnancy with childhood abdominal fat mass and liver fat fraction. Values are
regression coefficients (95% confidence intervals) from the confounder models that reflect the difference in (A) childhood outcomes in SDS and
(B) childhood outcomes in standardized residuals in children of mothers who consumed 2-3.9, 4-5.9, and ≥6 units of caffeine per day, as
compared with those whose mothers consumed <2 units of caffeine per day. One unit of caffeine represents the equivalent of one cup of coffee
(90 mg). The models are adjusted for child's sex, child's age at follow-up measurement, maternal ethnicity, maternal education, maternal smoking,
maternal alcohol use, folic acid supplementation, and television watching time. P values for trend were obtained from models in which the
categorized caffeine intake variable (<2, 2-3.9, 4-5.9, and ≥6 units) was entered as continuous variable
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This might be explained by subcutaneous fat being the main com-
partment of fat storage across the full body. Thus, maternal caffeine
intake throughout pregnancy might affect offspring visceral and liver
fat deposition, independent from their total amount of body fat.
The mechanisms underlying the observed associations are not
well known. Studies in adults have suggested that consumption of
caffeine-containing beverages might increase adiponectin concentra-
tions and decrease concentrations of pro-inflammatory cytokines,
subsequently influencing visceral and liver fat masses.15,19 Although
high maternal adiponectin concentrations during pregnancy have been
related to a higher risk of childhood obesity,20 the role of adipokines
and cytokines in the association of maternal caffeine intake during
pregnancy with offspring fat deposition is unknown. We speculate
that caffeine intake by pregnant women may affect adiponectin con-
centrations and the pro-inflammatory state, which may affect fetal
nutrient supply and subsequently lead to developmental adaptations
in adipose tissue. Alternatively, animal studies have suggested that in
utero exposure to caffeine may overexpose the developing fetus to
glucocorticoids, leading to an altered development of the HPA-
axis.43,44 High glucocorticoid concentrations have been related to
increased central obesity. In addition, the concentration of glucocorti-
coid receptors is higher in visceral adipose tissue as compared with
other fat depots, possibly resulting in differential fat deposition in
these depots.45 Rats exposed to caffeine in utero had increased intra-
hepatic fat concentrations and increased susceptibility to NAFLD,23,24
possibly by similar mechanisms. Finally, the associations might be
explained by confounding by unhealthy lifestyle factors that are
shared within families. However, a negative control analysis among
50 943 participants showed stronger associations for maternal caf-
feine intake during pregnancy with the risk of childhood overweight
at the age of 3 years, as compared with those for paternal caffeine
intake at the time of their partners pregnancy.12 Similarly, in another
recent negative control analysis among 558 participants, maternal caf-
feine intake, but not paternal caffeine intake, was associated with
childhood body mass index and waist circumference at ages 5 and
10 years.13 These results suggest that an intra-uterine programming
mechanism might at least partly underlie these associations. Further
studies are needed to disentangle the mechanisms underlying the
associations of maternal caffeine intake and childhood abdominal and
liver fat deposition.
Our results are consistent with those of previous studies and fur-
ther highlight the importance of limiting maternal caffeine intake
during pregnancy with respect to its potential adverse effects on
long-term body fat development in the offspring. The current recom-
mendations for maternal caffeine intake during pregnancy range
between 200 and 300 mg per day and are based on the risks of
adverse pregnancy and birth outcomes.46-48 The most pronounced
effects observed in our study were for caffeine intakes above these
guidelines. However, the dose-response relationship in our and previ-
ous studies5,6,8-13 suggest that the adverse effects of maternal caf-
feine intake with respect to both pregnancy outcomes and long-term
body fat development are not restricted to high caffeine intakes, but
increase across the range of maternal caffeine intake. A review of
randomized controlled trials had insufficient evidence to confirm that
avoiding caffeine consumption during pregnancy is beneficial with
respect to adverse pregnancy outcomes.49 Based on our findings and
findings from other observational studies, further adequately powered
randomized controlled trials are needed to assess whether avoiding
caffeine consumption during pregnancy improves both pregnancy and
long-term offspring health outcomes, as compared with current rec-
ommendations. Our findings and findings from other observational
studies need to be incorporated in future guidelines regarding mater-
nal caffeine consumption during pregnancy, and these guidelines need
to further emphasize potential beneficial effects on offspring health
outcomes by further reducing caffeine intake during pregnancy below
the current recommendations.
4.2 | Strengths and limitations
This study was embedded in a large population-based cohort from
early pregnancy onwards, enabling us to prospectively study the asso-
ciations of interest. Of all participants with information on maternal
caffeine intake during pregnancy, 39.6% did not participate in the
follow-up measurements at age 10. This non-response might have led
to biased estimates if the associations of interest differ between par-
ticipants included and lost to follow up. This seems unlikely as only a
minor difference in maternal caffeine intake was observed between
these groups. However, the selection towards a higher educated,
healthier population might have affected the generalizability of our
results. Maternal caffeine intake might have been underreported, pos-
sibly leading to misclassification of the caffeine intake categories and
underestimation of the effect estimates. In accordance with the Dutch
Nutrition Centre, we assumed that coffee and tea were consumed in
cups of 125 mL.46 This might have differed between participants,
which may have led to some misclassification of maternal caffeine
intake. We only had data available about caffeine intake from coffee
and tea and not from other sources, such as soft drinks, energy drinks,
chocolate, and medications. However, at the time of data collection
(2002-2006), coffee and tea accounted for 70% and 26%, respec-
tively, of all caffeine consumed.50 We had data available on many pos-
sible confounders. However, residual confounding might still be
present, for example, by maternal and child's physical activity and die-
tary habits.
5 | CONCLUSIONS
Our results suggest that high maternal caffeine intake during preg-
nancy is associated with higher general body fat, abdominal subcuta-
neous and visceral fat mass and liver fat fraction in childhood. The
associations of maternal caffeine intake during pregnancy with child-
hood visceral fat mass and liver fat seem to be largely independent
from childhood total body fat mass. This suggests differential fat accu-
mulation in these depots, which may increase susceptibility to cardio-
metabolic disease.
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